Latest AI (Artificial Intelligence) News
AI Content Generation Market to Surpass $17 Billion by 2030
The Artificial Intelligence (AI) Content Generation market is projected to exceed $17 billion by 2030, representing 6% of the broader AI market at $302 billion. North America leads with $5,381 million in 2030, driven by short-form video platforms and digital publishing expansion. The USA is the largest country market, growing from $1,599 million in 2025 at 25% CAGR.
AI Makes 15 New Scientific Discoveries Across Fields
A video highlights 15 recent AI-driven discoveries in medicine, biology, materials science, physics, and climate research. Examples include AI-generated proofs for unsolved math conjectures, a cancer drug candidate entering phase 2 trials in 2026, and 528 potential lithium-ion conductors identified. AI also mapped uncharacterized protein structures for rare diseases and discovered a zirconium indium nickel superconductor in 3 months.
Anthropic Sues Trump Administration Over Pentagon 'Supply Chain Risk' Label
Anthropic filed lawsuits challenging the Pentagon's designation of it as a supply chain risk due to restrictions on military use of its AI Claude for mass surveillance and autonomous weapons. Defense Secretary Pete Hegseth demanded unrestricted use, leading to bans on Anthropic services by federal agencies.
Despite the dispute, Anthropic projects $14 billion revenue mostly from non-military customers.
Robotic Platform LIBRIS Integrates AI for Lipid Nanoparticle Design
University of Pennsylvania engineers developed LIBRIS, a microfluidic platform generating 1,000 LNP formulations per hour to create datasets for AI training in mRNA delivery like COVID vaccines. It addresses data scarcity in mapping lipid ratios to biological outcomes, enabling rational LNP design.
The system accelerates from thousands of lipid designs to high-throughput testing.
Canada Warns of AI-Generated Deepfake Government Impersonators
Scammers use AI deepfakes to impersonate officials like the Prime Minister for fraud, stealing money, data, or spreading misinformation. Red flags include unnatural speech, visual glitches, or unusual promotions; verify via official channels.
The Competition Bureau urges caution against urgent calls to action in videos or audio.
New AI Agent Revolutionizes COF Synthesis with 350% Crystallinity Boost
Omar Yaghi's team created a GPT-4o-based AI agent automating literature search, synthesis planning, and analysis for covalent organic frameworks (COFs). It achieved a 350% crystallinity increase in a benchmark material and synthesized a new unreported COF.
The system iteratively refines conditions, shifting COFs from lab promise to market potential.
Global Push for Statutory Licensing: AI Firms to Pay News Publishers
A new proposal called statutory licensing would mandate AI companies pay publishers for journalism used in training data, covering past and future content. This aims to compensate media for AI's use of their work in model development.
Pharma's AI Investments Herald 2026 as Year of Drug Deployment
Generate's AI-derived antibody GB-0895 for severe asthma enters Phase III trials, from discovery to this stage in five years. 2026 sees AI platform deals across pharma for broad discovery, beyond single targets.
Chai Discovery calls it the year of deployment after 2025's breakthroughs.
USC AI System Learns to Fix Its Own Knowledge Gaps in Real Time
USC Viterbi researchers developed an AI method allowing it to self-teach unknown information dynamically. This undergraduate-professor project enables real-time adaptation without prior training data.
Evogene to Showcase AI-Driven Pharma Discoveries at BIO-Europe Spring 2026
Evogene's ChemPass AI™ integrates molecular design with validation for efficient small-molecule candidates in pharma. The company will present achievements at the event, highlighting AI's role in discovery.